GNLX (Genelux) FCF Yield %: -21.44 (As of Jul. 02, 2026)


GNLX Genelux Corp GNLX
28 GF Score
Price $2.91
! 4 Warning Signs
View Full Analysis

What is Genelux FCF Yield %?

Genelux GNLX -3.97% 28 FCF Yield % is -21.44 as of Jul. 02, 2026. GuruFocus rates GNLX with a GF Score™ of 28/100. The stock has 4 warning signs investors should review. Among 1,414 Biotechnology companies, Genelux ranks worse than 68.03% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Genelux's Trailing 12-Month Free Cash Flow is $-27.88 Mil, and Market Cap is $130.49 Mil. Therefore, Genelux's FCF Yield % for today is -21.44%.

The historical rank and industry rank for Genelux's FCF Yield % or its related term are showing as below:

GNLX' s FCF Yield % Range Over the Past 10 Years
Min: -45.95   Med: -20.5   Max: -0.51
Current: -21.44


During the past 6 years, the highest FCF Yield % of Genelux was -0.51%. The lowest was -45.95%. And the median was -20.50%.

GNLX's FCF Yield % is ranked worse than
68.03% of 1414 companies
in the Biotechnology industry
Industry Median: -9.525 vs GNLX: -21.44

Genelux's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.


Genelux FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Genelux FCF Yield % Related Terms


Genelux FCF Yield % Historical Data

* Premium members only.

The historical data trend for Genelux's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genelux FCF Yield % Chart

Genelux Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial 0.00 0.00 -5.68 -26.37 -15.86

Genelux Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.46 -26.48 -17.96 -15.96 -25.73

GNLX vs ADCT, COYA, VXRT: FCF Yield % Comparison

For the Biotechnology subindustry, Genelux's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genelux FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genelux's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Genelux's FCF Yield % falls into.


GNLX
28GF Score
Genelux Corp GNLX
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genelux FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Genelux's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-26.366 / 166.28604
=-15.86%

Genelux's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-6.98 * 4 / 108.5128
=-25.73%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -21.44 mean?
Genelux (GNLX) has a FCF Yield % of -21.44 as of Jul. 02, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Genelux and its competitors. According to the industry distribution chart, Genelux ranks #962 out of 1414 companies in the Biotechnology industry, placing it in the top 68%.
Is Genelux's FCF Yield % too high?
Genelux's current FCF Yield % is -21.44. Based on the distribution chart, Genelux ranks #962 out of 1414 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Genelux has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Genelux's FCF Yield % compare to ADCT and COYA?
According to the Biotechnology industry distribution chart, Genelux ranks #962 out of 1414 companies for FCF Yield %. This places Genelux in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Genelux and its competitors. Genelux's current FCF Yield % is -21.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genelux stock overvalued right now?
Genelux (GNLX) has a current FCF Yield % of -21.44. The current FCF Yield % is -21.44. Genelux's overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Genelux (GNLX), the current FCF Yield % is -21.44 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genelux Business Description

Address 2625 Townsgate Road, Suite 230, Westlake Village, CA, USA, 91361
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
28GF Score

Get the complete analysis for GNLX

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.91
Price